An open trial of pemoline in drug-dependent delinquents with attention- deficit hyperactivity disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 8, 1996, Pages 1018-1024

  Riggs, Paula D ^a   Thompson, Laetitia L ^a   Mikulich, Susan K ^a   Whitmore, Elizabeth A ^a   Crowley, Thomas J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

adolescents; attention deficit hyperactivity disorder; conduct disorder; pemoline; substance abuse

Indexed keywords

PEMOLINE;

ADOLESCENT; ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; HUMAN; MALE; MINIMAL BRAIN DYSFUNCTION; MORBIDITY; PRIORITY JOURNAL; SUBSTANCE ABUSE;

EID: 0029816347     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199608000-00012     Document Type: Article

References (38)

1. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington, DC: American Psychiatric Association
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Barkley RA (1990), Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford
4. Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1989), The response of aggressive and non-aggressive ADHD children to two doses of methylphenidate. J Am Acad Child Adolesc Psychiatry 28:873-881
5. Biederman J, Newcorn J, Sprich S (1991), Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577
6. Bukstein O, Brent D, Kaminer Y (1989), Comorbidity of substance abuse and other psychiatric disorders in adolescents. Am J Psychiatry 146:1131-1141
7. Burg JS, Rasile DA, Davino SM, Major LF, Burright RG, Donovick PJ (1992), Normative data on the Gordon Diagnostic System in psychiatric and neurological populations. ADHD/Hyperactivity Newsl 18:2-4
8. Cottier L, Robins L, Heizer J (1989), The reliability of the CIDI-SAM. Br J Addict 84:801-814
9. Cottler LB, Schuckit MA, Helzer JE et al. (1995), The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend 38:59-69
10. Crowley TJ, Riggs PD (1995), Adolescent substance use disorder with conduct disorder, and comorbid conditions. NIDA Res Monogr 156:49-111
11. Fischer M, Newby RF (1993), Sensitivity of the Gordon Diagnostic System to the effects of stimulant therapy in children: a reanalysis. ADHD/Hyperactivity Newsl 19:2
12. Fischer M, Newby RF, Gordon M (1993), Who are the false negatives? ADHD/Hyperactivity Newsl 19:5-7
13. Gordon M, McClure F, Post E (1986),Interpretive Guide to the Gordon Diagnostic System. DeWitt, NY: Gordon Systems
14. Hinshaw S (1987), On the distinction between attention deficit/hyperactivity and conduct problems/aggression in child psychopathology. Psychol Bull 101:443-463
15. Hollingshead AB (1957), Two-Factor Index of Social Position. New Haven, CT: Yale University
16. Klorman R, Brumaghim JT, Salzman LF et al. (1988a), Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. J Abnorm Psychol 97:418-422
17. Klorman R, Coons HW, Brumaghim JT, Borgstedt AD, Fitzpatrick P (1988b), Stimulant treatment for adolescents with attention deficit disorder. Psychopharmacol Bull 24:88-92
18. Lahey BB, Schaughency EA, Hynd GW, Carlson CL, Nieves N (1987), Attention deficit disorder with and without hyperactivity: comparison of behavioral characteristics of clinic-referred chldren. J Am Acad Child Adolesc Psychiatry 26:718-723
19. Langer DH, Sweeney KP, Bartenbach DE, Davis PM, Menander KB (1986), Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. Drug Alcohol Depend 17:213-227
20. Mannuzza S, Gittelman-Klein R, Bessler A, Malloy P, LaPadula ML (1993), Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565-576
21. Mattes JA, Boswell L, Oliver H (1984), Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 41:1059-1063
22. Medical Economics Data (1994), Physicians' Desk Reference, 48th ed. Montvale, NJ: Medical Economics Data, pp 410-411
23. Moffitt TE (1993), Adolescence-limited and life-course-persistent antisocial behavior, a developmental taxonomy. Psychol Rev 100:674-701
24. Nelson W, Tong YL, Lee JK, Halberg F (1979), Methods for cosinorrhythmometry. Chronobiologia 6:305-323
25. Pelham WE, Greenslade KE, Vodde-Hamilton MA et al. (1990), Relative efficacy of long-acting CNS stimulants on children with attention-deficit hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 86:226-237
26. Pelham WE, Swanson J, Furman MB, Schwindt H (1995), Pemoline effects in children with ADHD: a time-response by dose-response analysis on classroom measures. J Am Acad Child Adolesc Psychiatry 34:1504-1513
27. Rasile DA, Burg JS, Rumsey RL, Burright RG, Donovick PJ (1993), The relationship between GDS scores and other measures of attention in MS patients and "healthy" adults. ADHD/Hyperactivity Newsl 19:10-11
28. Regier DA, Framer ME, Rae DS et al. (1990), Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511-2518
29. Robins LN (1978), Sturdy childhood predictors of adult antisocial behavior: replications from longitudinal studies. Psychol Med 8:611-622
30. Robins LN, McEvoy L (1990), Conduct problems as predictors of substance abuse. In: Straight and Devious Pathways from Childhood to Adulthood, Robins LN, Rutter M, eds. Cambridge, England: Cambridge University Press, pp 182-204
31. Robins LN, Wing J, Wittchen HU et al. (1988), The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069-1077
32. Rosenberg DR, Holttum J, Gershon S (1994), Pharmacologic treatment of substance abuse disorders. In: Textbook of Pharmacotherapy for Child and Adolescent Disorders. New York: Brunner/Mazel, pp 508-510
33. Tannock R, Schachar RJ, Carr RP, Logan GD (1989), Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children. Pediatrics 84:648-654
34. Taylor EA, Schachar R, Thorley G, Weiselberg HM, Everitt B, Rutter M (1987), Which boys respond to stimulant medications? A controlled trial of methylphenidate in boys with disruptive behavior. Psychol Med 17:121-143
35. Thompson LL, Riggs PD, Mikulich SK, Crowley TJ (in press), Contribution of ADHD symptoms to substance problems and delinquency in conduct disordered adolescents. J Abnorm Psychol
36. Wender PH, Reimherr FW, Wood DR (1981), Attention deficit disorder ("minimal brain dysfunction") in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry 38:449-456
37. Wilens TE (1994), Reuniting with an old friend: magnesium pemoline for attention deficit hyperactivity disorder. Presented at American Academy of Child and Adolescent Psychiatry, Institute IX: Advanced Topics in Psychopharmacology, Barbara Geller, MD, Chair. New York, October
38. Young SE, Mikulich SK, Goodwin MB et al. (1995), Treated delinquent boys' substance use: onset, pattern, relationship to conduct and mood disorders. Drug Alcohol Depend 37:149-162